Specific Biologics is developing a platform technology consisting of a dual-cleaving nuclease that can be safely delivered to cells for the treatment of various genetic diseases. It designed to exploit the cell's naturally occurring DNA repair pathways through enhanced repair or predictable deletions.

Biotechnology

Specific Biologics

The Toronto office focuses on research and development in biotechnology, supporting innovative pipelines and laboratory operations.

Toronto

Specific Biologics' headquarters in Ontario, CA, United States

People (9)

Jobs (0)

Other offices